Clinical TrialsSearch results
Number of results: 321
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Recruiting
- Prevention of severe oral mucositis by RINDERON-V Ointment 0.12% during radiotherapy for oral cavity and oropharynx tumor
- Oral cavity and oropharynx tumor
- Soutome Sakiko
- 2020-05-11
Recruiting
- Prognostic study of risk stratification among Japanese patients with chronic kidney disease and ischemic heart disease using gated myocardial perfusion SPECT
- Chronic kidney disease, Ischemic heart disease
- Cardiovascular research foundation
- 2009-04-30
Recruiting
- Prospective clinical study of switch to vibegron for overactive bladder patients with inadequate effect of antimuscarinics and mirabegron treatment
- Problem(s) Studied
- Imamura Ryoichi
- 2023-09-29
Recruiting
- SMASH (Steroid Mouthwash for the Prevention of Oral Mucositis in Breast Cancer Chemotherapy) trial
- breast cancer
- Kuba Sayaka
- 2024-07-22
Recruiting
- Study on prevention of hypercapnia by Nasal High Flow in patients with endoscopic submucosal dissection during intravenous anesthesia
- Esophagus cancer, Gastric cancer, Colorectal cancer
- Ayuse Takao
- 2019-08-26
Recruiting
- Study on the efficacy of ipragliflozin for prevention of chronic kidney disease in type 1 diabetes
- Type 1 diabetes
- Horie Ichiro
- 2023-03-14
Recruiting
- Study on the preventive effect of ramelteon on the onset of sleep disorder after general anesthesia in patients with autism spectrum disorder
- insomnia
- Ayuse Takao
- 2020-09-11
Recruiting
- Study to Evaluate the Efficacy and Safety of K-808 (pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment
- Primary Biliary Cholangitis
- Tanigawa Ryohei
- 2024-01-18